08 Nov Regulatory Strategy
Register below to receive Zoom link
Biomedical Innovation Fireside Chats
Session 5: Regulatory Strategy
Join regional program leaders for virtual “fireside chats” with biomedical entrepreneurs, investors, and industry experts. Conversations are aimed at early-stage academic innovators who need to quickly learn the essentials. Events will be held over Zoom and recorded. Learn more about the series and the rest of the sessions here.
Topics for discussion in this session will include:
- FDA Regulations
- Devices, Therapeutics, Diagnostics & Digital Health Tools
- Safety & Efficacy
About the Host
Joshua Kim, MS, is a BRAMS alum and affiliated assistant professor in the University of Washington School of Pharmacy. He has a diverse background in Quality Systems and Regulatory Affairs in Medical Device and Pharmaceutical Industries. Currently, he is the senior regulatory affairs specialist in Boston Scientific’s Peripheral Intervention Division as well as a regulatory representative for the Emerging Therapies Group. In his spare time, he consults on regulatory affairs and quality system matters through V Scale Consulting LLC.
